Kevin Cairns, MD
Pain Medicine · Ft Lauderdale, FLNPI 1316902372
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.1%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 51 manufacturers reported payments, led by Boston Scientific at 31.4% of the total. Among pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 563 payments — averaging $69.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$12K
- Nalu Medical, Inc.$8K
- Elliquence, LLC$6K
- Spinal Simplicity, LLC$3K
- Medtronic$2K
- Abbott$1K
- plus $7K from 45 others
Across 9 payments — averaging $2444.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertiflex, Inc.$16K
- Boston Scientific$6K
Across 5 payments — averaging $15,620 each. An ownership or investment interest held by the physician or an immediate family member.
- Spinal Simplicity, LLC$78K
What the payments were for
- Consulting fees$12,00031%
- Speaking & faculty fees$6,17516%
- Travel & lodging$3,5309%
- Food & beverage$17,15644%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nalu Neurostimulation System$7,445
- SUPERION$6,294
- GENERAL PAIN MANAGEMENT$1,845
- HA MINUTEMAN G3-R$1,595
- WaveWriter Alpha Prime 16$399
- Senza$395
- mild Device Kit$312
- Intracept$257
- Prospera$241
- EVEREST SPINAL SYSTEM$164
- INTELLIS ADAPTIVESTIM$160
- Mariner$142
- Superion ISS$142
- Superion Indirect Decompression System$137
- INTELLIS$131
- Iovera$122
- SPRINT PNS System$119
- SERRATO$117
- Evoke SCS$117
- StimQ Receiver Stimulator Kit Channel A US w Receiver$114
How this compares
$38,880 in reported general payments places this provider in the 95th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SprixKetorolac Tromethamine | 22 | $54,496 |
| Nucynta ErTapentadol Hcl | 25 | $28,375 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 424 | $14,128 |
| NucyntaTapentadol Hcl | 12 | $8,876 |
| ZtlidoLidocaine | 18 | $8,740 |
| MovantikNaloxegol Oxalate | 18 | $7,116 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 193 | $4,408 |
| Celecoxib | 93 | $2,792 |
| Pregabalin | 100 | $2,262 |
| Gabapentin | 185 | $2,086 |
| Fentanyl | 20 | $1,640 |
| Tizanidine Hcl | 156 | $1,596 |
| Zolpidem Tartrate ErZolpidem Tartrate | 26 | $1,059 |
| Morphine Sulfate ErMorphine Sulfate | 42 | $1,044 |
| Lidocaine | 18 | $1,020 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta Er, Nucynta | $80 | $37,25137 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $636 | $8,74018 claims |
| Redhill Biopharma Inc.Movantik | $44 | $7,11618 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate | $13 | $43413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Ft Lauderdale
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
- Michael GreeneMiddleburg$73K
- Nicholas BremerFernandina Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.